Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2003

01-07-2003 | Original Article

Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in japan

Authors: Takahiro Okamoto, Kojiro Shimozuma, Noriyuki Katsumata, Michiko Koike, Akinori Hisashige, Katsuhiro Tanaka, Shozo Ohsumi, Mitsue Saito, Naoto Shikama, Michihide Mitsumori, Chikako Yamauchi, Takanori Watanabe

Published in: Breast Cancer | Issue 3/2003

Login to get access
Metadata
Title
Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in japan
Authors
Takahiro Okamoto
Kojiro Shimozuma
Noriyuki Katsumata
Michiko Koike
Akinori Hisashige
Katsuhiro Tanaka
Shozo Ohsumi
Mitsue Saito
Naoto Shikama
Michihide Mitsumori
Chikako Yamauchi
Takanori Watanabe
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2003
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02966719

Other articles of this Issue 3/2003

Breast Cancer 3/2003 Go to the issue

Case Report

A case of breast cancer metastasizing to cervix after resection of pancreatic metastasis

Original Article

Evaluation of HER-2 status in breast carcinoma by fluorescencein situ hybridization and immunohistochemistry

Original Article

Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer

Original Article

Elevated serum ca15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer

Original Article

Combined antitumor activity of 7-Hydroxystaurosporine (UCN-01) and Tamoxifen against human breast carcinomain Vitro andin Vivo

Original Article

Dye-Guided Sentinel Node Biopsy Revisited; Validation and Observational Study from a Single Institute
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits